| Product Code: ETC6165754 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Armenia PCR-based Infectious Diseases Market Overview |
3.1 Armenia Country Macro Economic Indicators |
3.2 Armenia PCR-based Infectious Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Armenia PCR-based Infectious Diseases Market - Industry Life Cycle |
3.4 Armenia PCR-based Infectious Diseases Market - Porter's Five Forces |
3.5 Armenia PCR-based Infectious Diseases Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Armenia PCR-based Infectious Diseases Market Revenues & Volume Share, By Infection, 2021 & 2031F |
3.7 Armenia PCR-based Infectious Diseases Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.8 Armenia PCR-based Infectious Diseases Market Revenues & Volume Share, By PCR Technology, 2021 & 2031F |
3.9 Armenia PCR-based Infectious Diseases Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.10 Armenia PCR-based Infectious Diseases Market Revenues & Volume Share, By Testing, 2021 & 2031F |
3.11 Armenia PCR-based Infectious Diseases Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Armenia PCR-based Infectious Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Armenia |
4.2.2 Growing awareness about the benefits of PCR-based testing for accurate diagnosis |
4.2.3 Technological advancements in PCR testing leading to improved efficiency and accuracy |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in certain regions of Armenia |
4.3.2 High cost associated with PCR-based testing compared to conventional methods |
4.3.3 Lack of skilled healthcare professionals proficient in PCR testing techniques |
5 Armenia PCR-based Infectious Diseases Market Trends |
6 Armenia PCR-based Infectious Diseases Market, By Types |
6.1 Armenia PCR-based Infectious Diseases Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Tuberculosis PCR Test, 2021- 2031F |
6.1.4 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Hepatitis PCR Test, 2021- 2031F |
6.1.5 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Human Immunodeficiency Virus (HIV) PCR Test, 2021- 2031F |
6.1.6 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Influenza PCR Test, 2021- 2031F |
6.1.7 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Human Papilloma Virus (HPV) PCR Test, 2021- 2031F |
6.2 Armenia PCR-based Infectious Diseases Market, By Infection |
6.2.1 Overview and Analysis |
6.2.2 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Viral Infection, 2021- 2031F |
6.2.3 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Respiratory Tract Infection, 2021- 2031F |
6.2.4 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Sexually Transmitted Infection, 2021- 2031F |
6.2.5 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Hospital Acquired Infections, 2021- 2031F |
6.2.6 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Other Infections, 2021- 2031F |
6.3 Armenia PCR-based Infectious Diseases Market, By Pathogen |
6.3.1 Overview and Analysis |
6.3.2 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Viral, 2021- 2031F |
6.3.3 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Bacterial, 2021- 2031F |
6.3.4 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Fungal, 2021- 2031F |
6.3.5 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Protozoa, 2021- 2031F |
6.3.6 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Armenia PCR-based Infectious Diseases Market, By PCR Technology |
6.4.1 Overview and Analysis |
6.4.2 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By RT PCR, 2021- 2031F |
6.4.3 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Multiplex PCR, 2021- 2031F |
6.4.4 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Armenia PCR-based Infectious Diseases Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5.4 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Adults, 2021- 2031F |
6.6 Armenia PCR-based Infectious Diseases Market, By Testing |
6.6.1 Overview and Analysis |
6.6.2 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Laboratory Based Testing, 2021- 2031F |
6.6.3 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Point of Care Testing, 2021- 2031F |
6.7 Armenia PCR-based Infectious Diseases Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.3 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.5 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.6 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Clinics, 2021- 2031F |
6.7.7 Armenia PCR-based Infectious Diseases Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
7 Armenia PCR-based Infectious Diseases Market Import-Export Trade Statistics |
7.1 Armenia PCR-based Infectious Diseases Market Export to Major Countries |
7.2 Armenia PCR-based Infectious Diseases Market Imports from Major Countries |
8 Armenia PCR-based Infectious Diseases Market Key Performance Indicators |
8.1 Adoption rate of PCR-based testing in healthcare facilities |
8.2 Number of laboratories offering PCR testing services |
8.3 Rate of development and approval of new PCR-based diagnostic tests |
8.4 Investment in research and development of PCR technologies |
8.5 Number of healthcare professionals trained in PCR testing techniques |
9 Armenia PCR-based Infectious Diseases Market - Opportunity Assessment |
9.1 Armenia PCR-based Infectious Diseases Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Armenia PCR-based Infectious Diseases Market Opportunity Assessment, By Infection, 2021 & 2031F |
9.3 Armenia PCR-based Infectious Diseases Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.4 Armenia PCR-based Infectious Diseases Market Opportunity Assessment, By PCR Technology, 2021 & 2031F |
9.5 Armenia PCR-based Infectious Diseases Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.6 Armenia PCR-based Infectious Diseases Market Opportunity Assessment, By Testing, 2021 & 2031F |
9.7 Armenia PCR-based Infectious Diseases Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Armenia PCR-based Infectious Diseases Market - Competitive Landscape |
10.1 Armenia PCR-based Infectious Diseases Market Revenue Share, By Companies, 2024 |
10.2 Armenia PCR-based Infectious Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here